🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label extension study to Study 200622.In this study subject...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-11-13
Trial ID
NCT03306043
Treatments Being Tested
This study is aimed to assess the correct real-world use of a safety syring...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-02-01
Trial ID
NCT03021304
Treatments Being Tested
This is a multi-centre, placebo-controlled, double-blind, parallel-group st...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-11
Trial ID
NCT02281318
Treatments Being Tested
The purpose of the MEMORY trial is to compare the effects of mepolizumab wi...
Status
Terminated
Location
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Pneumologie
Start Date
2015-11-17
Trial ID
NCT02594332
Treatments Being Tested
This is a multi-center, open-label, long-term study of subcutaneously (SC) ...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-05-29
Trial ID
NCT02135692
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of mepo...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-07-14
Trial ID
NCT04965636
Treatments Being Tested
Mepolizumab is a humanized monoclonal antibody. In conditions where eosinop...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-03-07
Trial ID
NCT02836496
This is a proof of concept pilot study to investigate the efficacy of mepol...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-02
Trial ID
NCT04305678
Treatments Being Tested
This study is designed to assess pharmacokinetics and pharmacodynamics of m...
Status
Completed
Location
Spaulding Clinical Research
Start Date
2020-02-17
Trial ID
NCT04183192
Treatments Being Tested
Background: Hypereosinophilic syndrome (HES) is a blood disorder that caus...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2025-02-05
Trial ID
NCT06477653
Treatments Being Tested